Table 1 PAR1 expression in breast cancer patients
From: PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study
Western blotting PAR1 immunoreactivity | No. of patients* (%) | Patients with metastases†(%) |
|---|---|---|
Positive | 29/50 (58%) | 23/23 (100%) |
Negative | 21/50 (42%) | 0 |